ARCHIVES

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

This article is from The Cancer Letter archive.

Vol. 12 No. 05 | January 31, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs

September 8, 1978

Advisors say NCI needs to reach out to other fields.

July 15, 2005

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Act To Get Only One-Year Extension Now NCAB; ACCC, ACI Adopt Recommendations For changes

February 4, 1977